NEW YORK (GenomeWeb) – Molecular diagnostics firm T2 Biosystems this week filed with the US Securities and Exchange Commission to sell up to $100 million of its common stock through one or more future offerings.

According to the filing, the company is also seeking SEC approval for certain undisclosed shareholders to sell up to $43 million of the company's common stock from time to time. T2 said that it would not receive any of the proceeds from the sale of these securities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.